Assessing substance use disorder in persons with severe mental illness

Drake, Robert E.; Rosenberg, Stanley D.; Mueser, Kim T.

doi:10.1002/yd.23319960203

Cited by 71 publications

(51 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Roughly 60% of state prison inmates with mental health problems reportedly were under the influence of drugs or alcohol at the time of their index arrest (Ditton, 1999). This estimate is consistent with epidemiologic evidence on the co-morbidity between mental illness and addiction problems (Bartels et al, 1993;Drake, Rosenberg, & Mueser, 1996;Kessler et al, 1996). Combined together, these estimates suggest that mental illness is concentrated in the incarcerated population and it ranges in type of disorder and co-morbidity pattern.…”

Section: Need and Placement Difficulty Profile Of Male Prison Inmatessupporting

confidence: 66%

Community reintegration of prisoners with mental illness: A social investment perspective

Wolff

2005

International Journal of Law and Psychiatry

View full text Add to dashboard Cite

Responding effectively and efficiently to the needs of persons with mental illness returning to the community from prison requires identifying their differences in need and placement difficulties upon return and targeting reintegration investments to reflect these differences. This paper has three parts. The first part profiles the male special needs population in New Jersey prisons. These profiles describe behavioral health and criminal justice characteristics of 2715 male inmates with mental health problems, and are used to identify the scope and nature of the public's investment opportunity. The next part describes the costs associated with possible "investments." The special needs population is classified by need and placement difficulty, and then matched to reentry and community-based treatment programs. Costs are estimated for reentry planning and communitybased treatment for the first year post-release. The third part recommends an investment strategy and a set of operational changes that might minimize the loss and maximize the return on the public s investment dollar in mental health.

show abstract

Section: Need and Placement Difficulty Profile Of Male Prison Inmatessupporting

confidence: 66%

Community reintegration of prisoners with mental illness: A social investment perspective

Wolff

2005

International Journal of Law and Psychiatry

View full text Add to dashboard Cite

show abstract

“…The most widely accepted treatment modality for those with COD is an integrated treatment model (Dennison, 2005;Drake et al, 2001;Drake, Mercer-McFadden, & Muser, 1998;Drake, Rosenberg, & Mueser, 1996;Henry, 2004;Hills, 2000;Peters & Hills, 1997), which offers multidisciplinary trained staff who provide treatment for dual disorders in a single setting (Peters & Hills, 1997). However, implementation of such a model for inmates with CODs is difficult due to limited resources, lack of trained staff, lack of coordination among prison staff and services, and space constraints that limit the ability of prison administrators to separate offenders with CODs from the general population (Peters et al, 2004).…”

Section: Discussionmentioning

confidence: 99%

The Effects of Mental Health and Substance Abuse Disorders on Institutional Misconduct Among Female Inmates

Houser¹,

Belenko²,

Brennan³

2011

Justice Quarterly

127

View full text Add to dashboard Cite

“…Alcohol is the most commonly abused substance by people with schizophrenia, followed by cannabis and cocaine [6]. In addition, 58% to 90% of people with schizophrenia are dependent on nicotine [7,8], which is approximately three times the rate in the general United States population (Surgeon General's Report 2000; http://cdc.gov/tobacco/ sgr/sgr_2000/sgr/tobacco_charts.html).…”

Section: Introductionmentioning

confidence: 99%

Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?

Roth¹,

Brunette²,

Green

2005

Curr Psychiatry Rep

View full text Add to dashboard Cite

Substance use disorders (SUDs) are highly prevalent and are associated with poor outcomes among individuals with schizophrenia. Integrating treatments for both disorders improves outcomes. Numerous individual pharmacologic and psychosocial treatments have shown effectiveness at reducing substance use in individuals with a primary diagnosis of schizophrenia and co-occurring substance use disorders. Of these treatments, medications such as certain atypical antipsychotics and naltrexone, and psychosocial treatments such as contingency management, seem to be particularly promising. The development and evaluation of psychopharmacologic and psychosocial treatments for SUDs in schizophrenia would benefit from a better understanding of the neurobiological mechanisms underlying the effectiveness of such treatments. Several theories have been put forth to explain the heightened risk for SUDs in schizophrenia. Of these, brain reward circuitry dysfunction, hypothesized to be etiologically important in SUDs, may be an especially salient target for treatments aimed at the reduction of substance use in patients with schizophrenia. We review current pharmacologic and psychosocial treatments for SUDs in schizophrenia, and theoretical mechanisms underlying the increased risk for SUDs in this population. We propose that effective treatments may in part work through the modulation of brain reward circuitry dysfunction.

show abstract

Assessing substance use disorder in persons with severe mental illness

Abstract: Assessment of dually diagnosed patients consists of three steps: detection, diagnosis, and specialized assessment for treatment planning. Each of these is informed by recent research.

Cited by 71 publications

References 54 publications

Community reintegration of prisoners with mental illness: A social investment perspective

Community reintegration of prisoners with mental illness: A social investment perspective

The Effects of Mental Health and Substance Abuse Disorders on Institutional Misconduct Among Female Inmates

Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?

Contact Info

Product

Resources

About